Peter G.
- Country
- Czechia
- Department
- NA
Research Overview
Data & Insights
Has run more than one trial at 0 of 15 partner sites.
Specializations
Cardiovascular Therapeutics
Investigator Girman focuses on acute coronary syndrome, myocardial infarction, and chronic conditions such as heart failure and atherosclerotic cardiovascular disease.
- Acute Coronary Syndrome
- Heart Failure with Reduced Ejection Fraction
- Atherosclerotic Cardiovascular Disease
- Hypertension
- Calcific Aortic Valve Stenosis
These areas support advances in reducing major adverse cardiovascular events and improving long‑term cardiac outcomes.
Renal and Transplant Immunology
His work addresses chronic kidney disease, dialysis‑related anemia, and immune challenges in kidney and pancreas transplantation.
- Chronic Kidney Disease
- Antibody‑Mediated Rejection
- Kidney Transplant Recipients
- Dialysis‑Associated Anemia
- Delayed Graft Function
Efforts aim to improve graft survival, reduce immunologic complications, and enhance renal function preservation.
Metabolic and Lipid Management
Girman investigates disorders of glucose and lipid metabolism, including type 2 diabetes, obesity, and severe hypertriglyceridemia.
- Type 2 Diabetes Mellitus
- Obesity and Overweight
- Severe Hypertriglyceridemia
- Heterozygous Familial Hypercholesterolemia
- Lipoprotein(a) Elevation
These interests target cardiovascular risk reduction through metabolic control and lipid lowering strategies.
Rare Protein Misfolding Disorders
His portfolio includes diseases characterized by abnormal protein aggregation such as transthyretin amyloid cardiomyopathy and alpha‑1 antitrypsin deficiency.
- Transthyretin Amyloid Cardiomyopathy (ATTR‑CM)
- Alpha‑1 Antitrypsin Deficiency‑Associated Liver Disease
- C3 Glomerulopathy
- IgA Nephropathy
- Erythropoietic Protoporphyria
Research seeks novel therapeutic approaches to mitigate organ damage caused by protein deposition.
Pulmonary Vascular and Hepatology Research
He also contributes to studies on pulmonary arterial hypertension and chronic liver conditions such as primary biliary cholangitis.
- Pulmonary Arterial Hypertension
- Primary Biliary Cholangitis
- Cirrhosis of the Liver
- Fluid Overload in Heart Failure
- Obstructive Pulmonary Hypertension
These efforts aim to improve vascular function and liver health in high‑risk patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.